Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2018 Filed Jan 4, 2018 21:10 UTC |
WIINBERG ULFDirector
|
GrantDeferred Shares · Derivative | 4,339.64 | $3.89 Strike: $3.89 | $16,876.86 |
DisclosureSEC source: 0001288123-18-000002 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,339.64 Underlying: Common Stock · 4,339.64 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 02, 2018 Filed Jan 19, 2018 21:21 UTC Amendment |
Wright TimothyDirector
|
GrantDeferred Shares · Derivative | 1,944.802 | $3.89 Strike: $3.89 | $7,563.33 |
DisclosureSEC source: 0001288123-18-000005 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,944.802 Underlying: Common Stock · 1,944.802 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| January 02, 2018 Filed Jan 19, 2018 21:16 UTC Amendment |
JORDAN WADIHDirector
|
GrantDeferred Shares · Derivative | 5,271.859 | $3.89 Strike: $3.89 | $20,502.26 |
DisclosureSEC source: 0001288123-18-000004 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,271.859 Underlying: Common Stock · 5,271.859 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:38 UTC |
Baysal OzerChief Commercial Officer
|
SaleCommon Stock | 3,712 | $3.46 | $12,845.75 |
DisclosureSEC source: 0001288123-17-000044 · primary_doc.xml · nonDerivative · entry 2 Baysal Ozer · CIK 0001579446 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,790 F2 · kind: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.44 per share. F2 · price: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.44 per share. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:33 UTC |
Buell JenniferChief Communications Officer
|
SaleCommon Stock | 3,511 | $3.46 | $12,151.92 |
DisclosureSEC source: 0001288123-17-000043 · primary_doc.xml · nonDerivative · entry 2 Buell Jennifer · CIK 0001711184 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,656 F2 · kind: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and 3.43 per share. F2 · price: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and 3.43 per share. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:27 UTC |
Duncan AlexChief Technology Officer
|
SaleCommon Stock | 6,546 | $3.46 | $22,651.12 |
DisclosureSEC source: 0001288123-17-000042 · primary_doc.xml · nonDerivative · entry 2 Duncan Alex · CIK 0001711183 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,026 F2 · kind: Represents sales of shares sold solely to cover Federal, State and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.43 per share. F2 · price: Represents sales of shares sold solely to cover Federal, State and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.43 per share. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:21 UTC |
KLASKIN CHRISTINE MVP, Finance
|
SaleCommon Stock | 5,610 | $3.46 | $19,417.89 |
DisclosureSEC source: 0001288123-17-000041 · primary_doc.xml · nonDerivative · entry 2 KLASKIN CHRISTINE M · CIK 0001288123 · VP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,333 F2 · kind: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.43 per share. F2 · price: Represents sales of shares sold solely to cover Federal, state and local tax withholding requirements on the restricted shares settled and were sold at prices ranging between $3.49 and $3.43 per share. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 21:14 UTC |
Valentine KarenChief Legal Officer
|
SaleCommon Stock | 8,358 | $3.46 | $28,921.19 |
DisclosureSEC source: 0001288123-17-000040 · primary_doc.xml · nonDerivative · entry 2 Valentine Karen · CIK 0001437152 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,521 F2 · shares: Represents sales of shares sold solely to cover Federal , state and local tax on withholding requirements on the restricted shares settled and were sold at prices ranging between $3.495 and $3.44 per share. F2 · price: Represents sales of shares sold solely to cover Federal , state and local tax on withholding requirements on the restricted shares settled and were sold at prices ranging between $3.495 and $3.44 per share. Read SEC document |
| November 30, 2017 Filed Dec 4, 2017 21:14 UTC |
ARMEN GARO HChairman and CEO
|
OtherCommon Stock | 300,000 | $3.96 | $1,188,000.00 |
DisclosureSEC source: 0001288123-17-000039 · primary_doc.xml · nonDerivative · entry 1 ARMEN GARO H · CIK 0000935679 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,290,441 F1 · kind: Represents deposit of Agenus Inc. common shares into the Garo Armen 2017 2 Year AG GRAT. Read SEC document |
| October 30, 2017 Filed Oct 30, 2017 21:05 UTC |
ARMEN GARO HChairman and CEO
|
GrantCommon Stock | 40,388 | $3.61 | $145,853.18 |
DisclosureSEC source: 0001288123-17-000037 · primary_doc.xml · nonDerivative · entry 2 ARMEN GARO H · CIK 0000935679 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,590,441 Read SEC document |
| October 30, 2017 Filed Oct 31, 2017 14:08 UTC Amendment |
ARMEN GARO HChairman & CEO
|
PurchaseCommon Stock | 40,388 | $3.61 | $145,853.18 |
DisclosureSEC source: 0001288123-17-000038 · primary_doc.xml · nonDerivative · entry 2 ARMEN GARO H · CIK 0000935679 · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,590,441 Read SEC document |
| October 27, 2017 Filed Oct 30, 2017 21:05 UTC |
ARMEN GARO HChairman and CEO
|
GrantCommon Stock | 59,612 | $3.51 | $209,261.96 |
DisclosureSEC source: 0001288123-17-000037 · primary_doc.xml · nonDerivative · entry 1 ARMEN GARO H · CIK 0000935679 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,550,053 Read SEC document |
| October 27, 2017 Filed Oct 31, 2017 14:08 UTC Amendment |
ARMEN GARO HChairman & CEO
|
PurchaseCommon Stock | 59,612 | $3.51 | $209,261.96 |
DisclosureSEC source: 0001288123-17-000038 · primary_doc.xml · nonDerivative · entry 1 ARMEN GARO H · CIK 0000935679 · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,550,053 Read SEC document |
| October 09, 2017 Filed Dec 14, 2017 21:46 UTC |
ARMEN GARO HCEO and Chairman of the Board
|
GrantCommon Stock | 71,966 | $3.59 | $258,357.94 |
DisclosureSEC source: 0001288123-17-000045 · primary_doc.xml · nonDerivative · entry 1 ARMEN GARO H · CIK 0000935679 · CEO and Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,362,407 F1 · kind: Represents settlement of restricted shares awarded on July 1, 2015. Read SEC document |
| October 09, 2017 Filed Dec 14, 2017 21:38 UTC |
Baysal OzerChief Commercial Officer
|
GrantCommon Stock | 13,080 | $3.59 | $46,957.20 |
DisclosureSEC source: 0001288123-17-000044 · primary_doc.xml · nonDerivative · entry 1 Baysal Ozer · CIK 0001579446 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,502 F1 · kind: Represents settlement of restricted shares awarded on July 1, 2015. Read SEC document |
| October 09, 2017 Filed Dec 14, 2017 21:33 UTC |
Buell JenniferChief Communications Officer
|
GrantCommon Stock | 10,431 | $3.59 | $37,447.29 |
DisclosureSEC source: 0001288123-17-000043 · primary_doc.xml · nonDerivative · entry 1 Buell Jennifer · CIK 0001711184 · Chief Communications Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,167 F1 · kind: Represents settlement of restricted shares awarded on July 1, 2016. Read SEC document |
| October 09, 2017 Filed Dec 14, 2017 21:27 UTC |
Duncan AlexChief Technology Officer
|
GrantCommon Stock | 13,423 | $3.59 | $48,188.57 |
DisclosureSEC source: 0001288123-17-000042 · primary_doc.xml · nonDerivative · entry 1 Duncan Alex · CIK 0001711183 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,572 F1 · kind: Represents settlement of restricted shares awarded on July 1, 2015. Read SEC document |
| October 09, 2017 Filed Dec 14, 2017 21:21 UTC |
KLASKIN CHRISTINE MVP, Finance
|
GrantCommon Stock | 10,431 | $3.59 | $37,447.29 |
DisclosureSEC source: 0001288123-17-000041 · primary_doc.xml · nonDerivative · entry 1 KLASKIN CHRISTINE M · CIK 0001288123 · VP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,943 F1 · shares: Represents settlement of restricted shares awarded on July 1, 2015. Read SEC document |
| October 09, 2017 Filed Dec 14, 2017 21:14 UTC |
Valentine KarenChief Legal Officer
|
GrantCommon Stock | 24,824 | $3.59 | $89,118.16 |
DisclosureSEC source: 0001288123-17-000040 · primary_doc.xml · nonDerivative · entry 1 Valentine Karen · CIK 0001437152 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,879 F1 · kind: Represents settlement of restricted shares awarded on July 1, 2015. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 21:33 UTC |
Wright TimothyDirector
|
GrantDeferred Shares · Derivative | 1,742.288 | $4.13 Strike: $4.13 | $7,186.94 |
DisclosureSEC source: 0001288123-17-000036 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,742.288 Underlying: Common Stock · 1,742.288 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 21:29 UTC |
WIINBERG ULFDirector
|
GrantDeferred Shares · Derivative | 4,090.589 | $4.13 Strike: $4.13 | $16,873.68 |
DisclosureSEC source: 0001288123-17-000035 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,090.589 Underlying: Common Stock · 4,090.589 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 21:23 UTC |
JORDAN WADIHDirector
|
GrantDeferred Shares · Derivative | 4,242.093 | $4.13 Strike: $4.13 | $17,498.63 |
DisclosureSEC source: 0001288123-17-000034 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,242.093 Underlying: Common Stock · 4,242.093 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| September 03, 2017 Filed Sep 7, 2017 00:29 UTC |
Buell JenniferVP Research & External Affairs
|
GrantCommon Stock | 4,375 | $3.72 | $16,275.00 |
DisclosureSEC source: 0001288123-17-000033 · primary_doc.xml · nonDerivative · entry 1 Buell Jennifer · CIK 0001711184 · VP Research & External Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,736 F1 · kind: Represents the settlement of restricted stock awarded on September 3, 2013. Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 15:32 UTC |
Wright TimothyDirector
|
GrantDeferred Shares · Derivative | 2,006.081 | $3.58 Strike: $3.58 | $7,187.79 |
DisclosureSEC source: 0001288123-17-000029 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,006.081 Underlying: Comon Stock · 2,006.081 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 15:23 UTC |
WIINBERG ULFDirector
|
GrantDeferred Shares · Derivative | 4,709.928 | $3.58 Strike: $3.58 | $16,875.67 |
DisclosureSEC source: 0001288123-17-000028 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,709.928 Underlying: Common Stock · 4,709.928 shares Expires not disclosed F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 15:08 UTC |
JORDAN WADIHDirector
|
GrantDeferred Shares · Derivative | 4,186.603 | $3.58 Strike: $3.58 | $15,000.60 |
DisclosureSEC source: 0001288123-17-000026 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,186.603 Underlying: Common Stock · 4,186.603 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 15:32 UTC |
Wright TimothyDirector
|
GrantStock Option, Right to buy · Derivative | 2,500 | $3.91 Strike: $3.91 | $9,775.00 |
DisclosureSEC source: 0001288123-17-000029 · primary_doc.xml · derivative · entry 3 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2027-06-29 F3 · derivative.exercise_date: Options vest 100% on the on-year anniversary of the grant date. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 15:32 UTC |
Wright TimothyDirector
|
GrantStok Option, Right to buy · Derivative | 50,000 | $3.91 Strike: $3.91 | $195,500.00 |
DisclosureSEC source: 0001288123-17-000029 · primary_doc.xml · derivative · entry 2 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-06-29 F2 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the one-year anniversary of the grant date of the date of the Company's 2018 annual shareholder meeting. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 15:23 UTC |
WIINBERG ULFDirector
|
GrantStock Option, Roght to buy · Derivative | 50,000 | $3.91 Strike: $3.91 | $195,500.00 |
DisclosureSEC source: 0001288123-17-000028 · primary_doc.xml · derivative · entry 2 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-06-29 F2 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the grant date of the award or the date of the Company's 2018 annual shareholder meeting. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 15:14 UTC |
Sharp ShaliniDirector
|
GrantStock Option, Right to buy · Derivative | 50,000 | $3.91 Strike: $3.91 | $195,500.00 |
DisclosureSEC source: 0001288123-17-000027 · primary_doc.xml · derivative · entry 1 Sharp Shalini · CIK 0001377202 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-06-29 F1 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the one-year anniversary of the grant date or the date of the Company's 2018 annual shareholder meeting. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 14:57 UTC |
Corvese BrianDirector
|
GrantStock Option, Right to buy · Derivative | 2,500 | $3.91 Strike: $3.91 | $9,775.00 |
DisclosureSEC source: 0001288123-17-000025 · primary_doc.xml · derivative · entry 2 Corvese Brian · CIK 0001393207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2027-06-29 F2 · derivative.exercise_date: Option vest 100% on the one-year anniversary of the grant date. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 14:57 UTC |
Corvese BrianDirector
|
GrantStock Option, Right to buy · Derivative | 50,000 | $3.91 Strike: $3.91 | $195,500.00 |
DisclosureSEC source: 0001288123-17-000025 · primary_doc.xml · derivative · entry 1 Corvese Brian · CIK 0001393207 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-06-29 F1 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the one-year anniversary of the grant date or the date of the Company's 2018 annual shareholder meeting. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 15:08 UTC |
JORDAN WADIHDirector
|
GrantStock Optoin, Right to buy · Derivative | 2,500 | $3.91 Strike: $3.91 | $9,775.00 |
DisclosureSEC source: 0001288123-17-000026 · primary_doc.xml · derivative · entry 3 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2027-06-29 F3 · derivative.exercise_date: Option vests 100% on the one-year anniversary of the grant date. Read SEC document |
| June 29, 2017 Filed Jul 3, 2017 15:08 UTC |
JORDAN WADIHDirector
|
GrantStock Option, Right to buy · Derivative | 50,000 | $3.91 Strike: $3.91 | $195,500.00 |
DisclosureSEC source: 0001288123-17-000026 · primary_doc.xml · derivative · entry 2 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-06-29 F2 · derivative.exercise_date: Annual option award vesting 100% on the earlier of the one-year anniversary of the grant date or the date of the Company's 2018 annual shareholder meeting. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 20:13 UTC |
Valentine KarenChief Legal Officer
|
Disposition to issuerCommon Stock | 8,055 | $3.39 | $27,306.45 |
DisclosureSEC source: 0001288123-17-000022 · primary_doc.xml · nonDerivative · entry 2 Valentine Karen · CIK 0001437152 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,055 F2 · kind: Represents exclusively, shares withheld by Agenus Inc. in respect of payment of the withholding tax liability upon the vesting of the restricted shares. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 20:13 UTC |
Valentine KarenChief Legal Officer
|
GrantCommon Stock | 24,822 | $3.39 | $84,146.58 |
DisclosureSEC source: 0001288123-17-000022 · primary_doc.xml · nonDerivative · entry 1 Valentine Karen · CIK 0001437152 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,110 F1 · kind: Represents settlement of vested restricted shares granted on July 1, 2015. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 20:06 UTC |
ARMEN GARO HChairman & CEO
|
GrantCommon Stock | 71,964 | $3.39 | $243,957.96 |
DisclosureSEC source: 0001288123-17-000021 · primary_doc.xml · nonDerivative · entry 1 ARMEN GARO H · CIK 0000935679 · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,490,441 F1 · kind: Represents settlement of vested restricted shares granted on July 1, 2015. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 20:29 UTC |
KLASKIN CHRISTINE MVP, Finance
|
Disposition to issuerCommon Stock | 3,733 | $3.39 | $12,654.87 |
DisclosureSEC source: 0001288123-17-000024 · primary_doc.xml · nonDerivative · entry 2 KLASKIN CHRISTINE M · CIK 0001288123 · VP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,512 F2 · kind: Represents exclusively, shares withheld by Agenus Inc. in respect of payment of the withholding tax liability upon the vesting of the restricted shares. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 20:29 UTC |
KLASKIN CHRISTINE MVP, Finance
|
GrantCommon Stock | 10,429 | $3.39 | $35,354.31 |
DisclosureSEC source: 0001288123-17-000024 · primary_doc.xml · nonDerivative · entry 1 KLASKIN CHRISTINE M · CIK 0001288123 · VP, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,245 F1 · kind: Represents settlement of vested restricted shares granted on July 1, 2015. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 20:23 UTC |
Baysal OzerChief Business Officer
|
Disposition to issuerCommon Stock | 3,539 | $3.39 | $11,997.21 |
DisclosureSEC source: 0001288123-17-000023 · primary_doc.xml · nonDerivative · entry 2 Baysal Ozer · CIK 0001579446 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,422 F2 · kind: Represents exclusively, shares withheld by Agenus Inc. in respect of payment of the withholding tax liability upon the vesting of the restricted shares. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 20:23 UTC |
Baysal OzerChief Business Officer
|
GrantCommon Stock | 13,078 | $3.39 | $44,334.42 |
DisclosureSEC source: 0001288123-17-000023 · primary_doc.xml · nonDerivative · entry 1 Baysal Ozer · CIK 0001579446 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,961 F1 · kind: Represents settlement of vested restricted shares granted on July 1, 2015. Read SEC document |
| April 12, 2017 Filed Apr 12, 2017 21:41 UTC |
ARMEN GARO HDirector · Chairman & CEO
|
PurchaseCommon Stock | 29,456 | $3.29 | $97,054.57 |
DisclosureSEC source: 0000899243-17-010077 · doc4.xml · nonDerivative · entry 2 ARMEN GARO H · CIK 0000935679 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,418,477 F2 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.255 to $3.33. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares purchased at each price. Read SEC document |
| April 10, 2017 Filed Apr 12, 2017 21:41 UTC |
ARMEN GARO HDirector · Chairman & CEO
|
PurchaseCommon Stock | 70,544 | $3.37 | $237,465.21 |
DisclosureSEC source: 0000899243-17-010077 · doc4.xml · nonDerivative · entry 1 ARMEN GARO H · CIK 0000935679 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,389,021 F1 · price: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $3.29 to $3.43. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares purchased at each price. Read SEC document |
| April 03, 2017 Filed Apr 6, 2017 20:39 UTC |
Wright TimothyDirector
|
GrantDeferred Shares · Derivative | 1,586.909 | $4.04 Strike: $4.04 | $6,406.35 |
DisclosureSEC source: 0001288123-17-000020 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,586.909 Underlying: Common Stock · 1,586.909 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| April 03, 2017 Filed Apr 6, 2017 20:29 UTC |
JORDAN WADIHDirector
|
GrantDeferred Shares · Derivative | 3,715.69 | $4.04 Strike: $4.04 | $15,000.24 |
DisclosureSEC source: 0001288123-17-000018 · primary_doc.xml · derivative · entry 1 JORDAN WADIH · CIK 0001222090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,715.69 Underlying: Common Stock · 3,715.69 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| April 03, 2017 Filed Apr 6, 2017 20:34 UTC |
WIINBERG ULFDirector
|
GrantDeferred Shares · Derivative | 3,406.049 | $4.04 Strike: $4.04 | $13,750.22 |
DisclosureSEC source: 0001288123-17-000019 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,406.049 Underlying: Common Stock · 3,406.049 shares Expires not disclosed F1 · security: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.exercise_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. F1 · derivative.expiration_date: Acquired under the Agenus Inc. Director Deferred Compensation Plan, as amended. Deferred Shares represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:49 UTC |
ARMEN GARO HChairman and CEO
|
GrantStock Option, Right to Buy · Derivative | 853,000 | $3.77 Strike: $3.77 | $3,215,810.00 |
DisclosureSEC source: 0001288123-17-000014 · primary_doc.xml · derivative · entry 2 ARMEN GARO H · CIK 0000935679 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 853,000 Underlying: Common Stock · 853,000 shares Expires 2027-03-31 F2 · derivative.exercise_date: Option vests 100% on 5-year anniversary of the award provided Dr. Armen maintains a service relationship with the Company on such date. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:49 UTC |
ARMEN GARO HChairman and CEO
|
GrantRestricted Stock Unit · Derivative | 647,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001288123-17-000014 · primary_doc.xml · derivative · entry 1 ARMEN GARO H · CIK 0000935679 · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 647,000 Underlying: Common Stock · 647,000 shares Expires 2022-03-31 F1 · derivative.exercise_price: Award vests on March 31, 2022 if and only if the 20-day average closing price of the Company's common stock on March 31, 2022 is greater than or equal to $15 per share provided Dr. Armen maintains a service relationship with the Company at all times through such date. F1 · price: Award vests on March 31, 2022 if and only if the 20-day average closing price of the Company's common stock on March 31, 2022 is greater than or equal to $15 per share provided Dr. Armen maintains a service relationship with the Company at all times through such date. F1 · derivative.exercise_date: Award vests on March 31, 2022 if and only if the 20-day average closing price of the Company's common stock on March 31, 2022 is greater than or equal to $15 per share provided Dr. Armen maintains a service relationship with the Company at all times through such date. F1 · derivative.expiration_date: Award vests on March 31, 2022 if and only if the 20-day average closing price of the Company's common stock on March 31, 2022 is greater than or equal to $15 per share provided Dr. Armen maintains a service relationship with the Company at all times through such date. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 23:00 UTC |
WIINBERG ULFDirector
|
GrantRestricted Stock Unit · Derivative | 15,915 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001288123-17-000017 · primary_doc.xml · derivative · entry 1 WIINBERG ULF · CIK 0001187314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,915 Underlying: Common Stock · 15,915 shares Expires 2018-03-31 F1 · derivative.exercise_price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. F1 · price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. F1 · derivative.exercise_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. F1 · derivative.expiration_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 22:56 UTC |
Wright TimothyDirector
|
GrantRestricted Stock Unit · Derivative | 15,915 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001288123-17-000016 · primary_doc.xml · derivative · entry 1 Wright Timothy · CIK 0001383313 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,915 Underlying: Common Stock · 15,915 shares Expires 2018-03-31 F1 · derivative.exercise_price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. F1 · price: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. F1 · derivative.exercise_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. F1 · derivative.expiration_date: Award vests 100% on the one-year anniversary of the grant date provided the director continues to serve on the Board on such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.